Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0851184 (
thinning
)
11,252
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report about a boy with nonketotic hyperglycinemia who was studied at 15 days of life with a follow-up examination at age 6 months. Magnetic resonance (MR) imaging revealed progressive atrophy, callosal
thinning
, and delayed myelination.
Glycine
peaks were shown by proton MR spectroscopy at 3.56 ppm with a long echo time (TE, 135 milliseconds; TR, 1500 milliseconds). Echo-planar diffusion MR imaging (TR, 5700 milliseconds; TE, 139 milliseconds) at 15 days of life revealed high-signal lesions in the pyramidal tracts, middle cerebellar pedicles, and dentate nuclei on b = 1000 s/mm2 images associated with low apparent diffusion coefficient (ADC) values. By age 6 months, the lesions became more prominent on b = 1000 s/mm2 images with lower ADC values. Diffusion MR imaging findings likely reflected the histopathologic changes of the disease which consisted of spongiosis of the myelinated brain tissue due to myelin vacuolation.
...
PMID:Nonketotic hyperglycinemia: diffusion magnetic resonance imaging findings. 1288 39
Gly
-Leu-Phe (GLF), an immunostimulating peptide derived from alpha-lactalbumin, prevented alopecia induced by an anticancer agent etoposide in a neonatal rat model after intraperitoneal injection at a dose of 100 mg/kg for 4 d or oral administration at a dose of 300 mg/kg for 6 d. By microscopic analysis of skin sections, GLF proved to inhibit etoposide-induced loss of hair, thickening of the epidermis, and
thinning
of the adipocyte layer. The anti-alopecia effect of GLF was inhibited by pyrilamine, a histamine H1 receptor antagonist, suggesting that the anti-alopecia effect is mediated by histamine release.
...
PMID:Anti-alopecia effect of Gly-Leu-Phe, an immunostimulating peptide derived from alpha-lactalbumin. 1611
It is difficult to clearly and unambiguously demonstrate an allelopathic mechanism of plant interference. Several types of experimental methodologies such as the additive design, substitutive designs, and several types of plant yield-plant population functions are discussed in terms of their relative merits in terms of providing quantitative and qualitative information in the development of an empirical basis to describe a plant interaction. Additionally, several types of mathematical and graphical representations are presented using data from the velvetleaf (Abutilon theophrasti) and soybean (
Glycine
max) interaction. The design provides agronomically relevant information about crop yield losses but confounds the separate effects of population density and species proportion in mixtures. The replacement series design separates these two variables by maintaining a constant population of plants while varying the relative proportion of each species in mixtures. The replacement series diagram, relative yield, relative replacement rate, ratio diagram, a scaling test, and the regression of individual yield on the associate yield are discussed in terms of their utility in providing insights into a plant interaction. Individual plant yield-plant population functions such as the "Y-D" and "C-D" effects, the "3/2 power law of self-
thinning
," and the "Sakai" test provide a basis to compare plant yield per plant versus plant population responses. Several types of interactions are characterized with this methodology. None of these experimental designs will clearly demonstrate an allelopathic plant interaction alone, but they do provide high-inference experimental methodologies to develop an empirical foundation to describe accurately a plant interaction upon which more specific hypotheses can be developed.
...
PMID:Experimental methodologies to evaluate allelopathic plant interactions : TheAbutilon theophrasti-Glycine max model. 2440 93